Based on the amendment of the Health Insurance Act that enters into force on 1 January 2025 (given 19 December 2024) the confirmed reasonable wholesale prices of reimbursable medicinal products authorised in 2010 and thereafter will be reduced by 1.5 per cent on 1 March 2025.
The reduction in wholesale prices does not apply to biological medicinal products belonging to a reference price group based on a biosimilar product or to parallel-imported medicinal products, when a reimbursable direct-imported medicinal product is not in the wholesale price reduction procedure. The reduction in wholesale prices does not apply to the maximum wholesale prices of medicinal products belonging to a reference price group based on a generic product in the reference price system either.
A list of medicinal products reimbursed on 1 Mach 2025 is attached to this notice. Products belonging to a reference price group based on a generic or biosimilar product, products with conditional reimbursement status and products authorised before 2010 are excluded from the list. The list is based on 20 December 2024.
Further information
hila.stm(at)gov.fi
Annex (in Finnish): List of reimbursable medicinal products 1 March 2025 (situation 20.12.2024)